News & Updates

Metformin lowers HCC risk after antiviral therapy in diabetic patients with hepatitis C
Metformin lowers HCC risk after antiviral therapy in diabetic patients with hepatitis C
11 Feb 2023
Novel KRAS G12C inhibitor shows promising antitumour activity in mutated pancreatic cancer
Novel KRAS G12C inhibitor shows promising antitumour activity in mutated pancreatic cancer
11 Feb 2023
Is first-line lazertinib monotherapy a potential new SoC for EGFRm NSCLC?
Is first-line lazertinib monotherapy a potential new SoC for EGFRm NSCLC?
10 Feb 2023 byRoshini Claire Anthony

Patients with EGFR-mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) exhibited significantly improved progression-free survival (PFS) when treated with lazertinib compared with gefitinib in the first-line setting, results of the LASER301 trial showed.

Is first-line lazertinib monotherapy a potential new SoC for EGFRm NSCLC?
10 Feb 2023
Machine-learning algorithm detects diabetes class from ECG
Machine-learning algorithm detects diabetes class from ECG
10 Feb 2023